09.7
[]. Hernandez-Ilizaliturri FJ, et al. Immunomodulatory drug CC-03 or CC-4047 and rituximab enhance antitumor activity in a severe combined immunodeficient mouse lymphoma model. Clin Cancer Res. 00 Aug ;(6):984-9.
[]. Li Z, et al. Pomalidomide shows significant therapeutic activity against CNS lymphoma with a major impact on the tumor microenvironment in murine models. PLoS One. 03 Aug ;8(8):e774.
[3]. Liu D, et al. Tumour necrosis factor-α inhibits hepatic lipid deposition through GSK-3β/β-catenin signaling in juvenile turbot (Scophthalmus maximus L.). Gen Comp Endocrinol. 06 Mar ;8:-8.
[4]. Lu J, et al. Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4. Chem Biol. 0 Jun 8;(6):7-63.
[]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 09;3():-6.
H30-H3-H39-H33
P6-P64-P70-P7-P80-P30+P3-P304+P340-P30+P3+P338-P330-P36+P364-P403+P33-P40-P0